Modus QA, Quasar MRID3D

July 31, 2016 — Modus QA updated its Quasar MRID3D with faster isocenter detection, improved fiducial markers, convenient alignment crosshairs and additional visualization tools, improving its lightweight, large field of view MRgRT QA Phantom.

Featuring an acrylic hollow twin cylinder wall enclosure, Quasar MRID3D now contains 1,502 precisely machined fiducial markers with six larger central reference fiducials for robust detection when imaging SNR is low or distortion is high i.e. while vendor geometric distortion correction is turned off. The system uses a sophisticated 3-D DICOM viewer with ROI selector, which takes geometric distortion analysis to a higher level with the ability to update charts and graphs in real-time to gain further insights. The ergonomic phantom is designed with built-in three point contact feet for quick set-up on uneven surfaces and integrated handles for convenient handling.

The system aids next generation LINACs with its quick and easy set-up, fast scan times, simple workflow and rapid calculations of results. The updated Qausar MRID3D features enriched analysis tools making it easier to examine the geometric distortion measurements of a single acquisition or compare the distortion among a collection of images. Interactive statistical graphics empower users to explore, discover, summarize and visualize quantitative data in the way they see fit to form conclusions and make decisions.

Now with automated processes to identify location of control points, calculate distortion vector fields, quantify geometric distortion and produce statistical analysis, the system is a good phantom for MRI QA. It comes with easy-to-use image analysis software to perform complex calculations and execute elegant algorithms to calculate the phantom boundary distortion vector field, volumetric 3-D distortion vector field and B0 distortion vs. gradient distortion.

Following the introduction of custom settings, the analysis software feature list continues to grow, giving users added flexibility and capabilities to display data their way by adjusting threshold settings, regions of interest, image viewer properties, graphic display resolution, plot line colors and database configurations.

The 21 kg pre-filled Quasar MRID3D acrylic phantom measuring 39.4 cm diameter by 39.1 cm long comes complete and ready to use with analysis software for quantifying geometric distortion MR images in 3-D.

For more information: modusqa.com/imaging/phantoms/mrid3d


Related Content

News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Insurance expansions under the Affordable Care Act (ACA) were linked with an increase in patients ...

Time May 10, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Subscribe Now